Physician profile
Anna Wong
NPI 1215310255
$4,454.88
in general payments reported to CMS, 2019-2025
22 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2020: $473 · 2021: $146 · 2022: $136 · 2023: $931 · 2024: $700 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,700 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,699.82 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $687.52 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $665.99 | 2022-2025 | Miebo, Xiidra, Doctors Allergy Formula |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $501.44 | 2019-2021 | |
| Glaukos Corporation | $486.01 | 2019-2024 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Idose |
| Dompe US, INC. | $315.02 | 2019-2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $247.71 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $212.30 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $196.07 | 2025 | Tryptyr, Simbrinza, Hydrus Microstent |
| Oyster Point Pharma, INC. | $186.12 | 2023-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $168.63 | 2023-2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $124.99 | 2019 | |
| Amgen INC. | $114.95 | 2024-2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $114.50 | 2025 | Catalys System, Tecnis Iol, Veritas Vision System |
| Shire North American Group INC | $109.04 | 2019 | |
| Rxsight INC | $88.43 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $68.39 | 2023-2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $63.75 | 2020-2023 | Flarex |
| Abbvie INC. | $23.68 | 2022 | |
| Astellas Pharma US INC | $22.22 | 2024 | Izervay |
| Allergan, INC. | $21.48 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.